Friday, August 31, 2012
Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., closed its registered direct offering of 4 million shares of common stock and warrants to purchase 1.2 million shares of common stock, generating gross proceeds of $6 million. Roth Capital Partners acted as the exclusive placement agent.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.